Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
Bichat guidelines for the clinical management of plague and bioterrorism-related plague
Abstract
Yersinia pestis appears to be a good candidate agent for a bioterrorist attack. The use of an aerosolised form of this agent could cause an explosive outbreak of primary plague pneumonia. The bacteria could be used also to infect the rodent population and then spread to humans. Most of the therapeutic guidelines suggest using gentamicin or streptomycin as first line therapy with ciprofloxacin as optional treatment. Persons who come in contact with patients with pneumonic plague should receive antibiotic prophylaxis with doxycycline or ciprofloxacin for 7 days. Prevention of human-to-human transmission via patients with plague pneumonia can be achieved by implementing standard isolation procedures until at least 4 days of antibiotic treatment have been administered. For the other clinical types of the disease, patients should be isolated for the first 48 hours after the initiation of treatment.
Source and rights
Published by Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2004. The guideline itself is at the source linked here.
Prognia summarises this guideline for reference and education. It is not medical advice. Always check the official guideline and current local protocols before acting on it.
At a glance
- Published
- 2004
- Applies to
- 🌐 International
- Country of origin
- 🇱🇺 Luxembourg
- Scope
- International
- Journal
- Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin




